Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Giulio Garaffa, MD, PhD"'
Autor:
Daniar Osmonov, MD, PhD, FECSM, Ahmed Ragheb, MD, PhD, FECSM, Sam Ward, MD, FEBU, FECSM, Gideon Blecher, MD, FECSM, Marco Falcone, MD, PhD, FECSM, Armin Soave, MD, PhD, FEBU, FECSM, EAA, Roland Dahlem, MD, PhD, Koenraad van Renterghem, MD, PhD, Nim Christopher, MD, PhD, Georgios Hatzichristodoulou, MD, PhD, FEBU, FECSM, Mirko Preto, MD, PhD, Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng), Maarten Albersen, MD, PhD, FEBU, FECSM, Carlo Bettocchi, MD, PhD, FECSM, Giovanni Corona, MD, PhD, FECSM, Yacov Reisman, MD, PhD, FECSM
Publikováno v:
Sexual Medicine, Vol 10, Iss 1, Pp 100459- (2022)
Introduction: Patients with Peyronie's disease may experience significat distress. The choice of treatment depends on a variety of factors, including the stage of the disease, the presence of pain, severity and direction of the curvature, penile leng
Externí odkaz:
https://doaj.org/article/bf08b81ccd7848f78d6c5c756b61eea8
Autor:
Fabio Castiglione, MD, Petter Hedlund, MD, PhD, Emanuel Weyne, MD, PhD, Lukman Hakim, MD, Francesco Montorsi, MD, Trinity J. Bivalacqua, MD, PhD, Dirk De Ridder, MD, PhD, PhD, Uros Milenkovic, MD, David Ralph, MD, Giulio Garaffa, MD, PhD, Asif Muneer, MD, PhD, Steven Joniau, MD, Maarten Albersen, MD, PhD
Publikováno v:
Sexual Medicine, Vol 7, Iss 1, Pp 94-103 (2019)
Introduction: Previous studies have shown that the injection of adipose tissue–derived stem cells (ADSCs) into the tunica albuginea (TA) during the active phase of Peyronie’s disease (PD) prevents the development of fibrosis. Aim: To investigate,
Externí odkaz:
https://doaj.org/article/9cd0a708737c49658fb5d2ca4c6869e4